Comorbid conditions in Gilbert’s syndrome in children
https://doi.org/10.31146/1682-8658-ecg-233-1-96-98
Abstract
The study of comorbid pathology in Gilbert’s syndrome is an important area in medical genetics and pediatrics. An important feature of Gilbert’s syndrome is that its clinical manifestations can vary from an asymptomatic course to the appearance of a number of comorbid conditions, such as diseases of the gastrointestinal tract and the biliary system. Its study makes it possible to better understand the mechanism of development of these conditions, to develop effective diagnostic and therapeutic approaches.
About the Authors
A. I. Batdalova
Saratov State Medical University named after V.I. Razumovsky (Razumovsky University)
Russian Federation
Russian Federation
K. F. Ildarov
Saratov State Medical University named after V.I. Razumovsky (Razumovsky University)
Russian Federation
Russian Federation
T. M. Batchaeva
Saratov State Medical University named after V.I. Razumovsky (Razumovsky University)
Russian Federation
Russian Federation
D. V. Ovakimian
Saratov State Medical University named after V.I. Razumovsky (Razumovsky University)
Russian Federation
Russian Federation
Yu. V. Chernenkov
Saratov State Medical University named after V.I. Razumovsky (Razumovsky University)
Russian Federation
Russian Federation
O. I. Gumeniuk
Saratov State Medical University named after V.I. Razumovsky (Razumovsky University)
Russian Federation
Russian Federation
References
1. Reyzis R., Khokhlova O.N., Nikitina T.S. Gilbert’s Syndrome: Current Insights, Outcomes and Therapies. Doctor.ru. Gastroenterology. 2012;3(71):42-45. (in Russ.)@@ Рейзис А.Р., Хохлова О.Н., Никитина Т.С. Синдром Жильбера: современные воззрения, исходы и терапия. Доктор.ру. Гастроэнтерология. 2012;3(71): 42-45.
2. Wagner K.H., Shiels R.G., Lang C.A., Seyed K., Bulmer A.C. Diagnostic criteria and contributors to Gilbert’s syndrome. Critical Reviews in Clinical Laboratory Sciences. 2018; 55(2): 129-139. doi: 10.1080/10408363.2018.1428526.
3. King D., Armstrong M. Overview of Gilbert’s syndrome. Drug and Therapeutics Bulletin. 2019;57:27-31.
4. Gilbert A., Lereboullet P. [La cholémie simple familiale]. La Semaine Médicale. 1901; 21: 241-3.
5. Strassburg C.P. Gilbert-Meulengracht’s syndrome and pharmacogenetics: is jaundice just the tip of the iceberg? Drug Metab Rev. 2010;42(1):168-81. doi: 10.3109/03602530903209429.
6. Loshkova E.V., Doroshenko I.V., Yankina G.N. et al. Gilbert’s syndrome as a model for studying the effects of bilirubin. Experimental and Clinical Gastroenterology. 2022;(10):126-141. (In Russ.) doi: 10.31146/1682-8658-ecg-206-10-126-141.@@ Лошкова Е.В., Дорошенко И.В., Янкина Г.Н.и др. Синдром Жильбера как модель изучения эффектов билирубина. Экспериментальная и клиническая гастроэнтерология. 2022;(10):126-141. doi: 10.31146/1682-8658-ecg-206-10-126-141
7. Dubrovina G.M., Botvinyev O.K., Kolotilina A.I.Combination of Gilbert’s syndrome and gastrointestinal diseases.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2014;24(3):13-21. (In Russ.)@@ Дубровина Г.М., Ботвиньев О.К., Колотилина А.И. Сочетание синдрома Жильбера с заболеваниями желудочно-кишечного тракта. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2014;24(3):13-21.
8. Kamal S., Abdelhakam S., Ghoraba D. et al. The frequency, clinical course, and health related quality of life in adults with Gilbert’s syndrome: a longitudinal study. BMC Gastroenterol. 2019;19(1):22. doi: 10.1186/s12876-019-0931-2.
9. Ehmer U., Kalthoff S., Fakundiny B., Pabst B., Freiberg N., Naumann R., Manns M.P., Strassburg C.P. Gilbert syndrome redefined: a complex genetic haplotype influences the regulation of glucuronidation. Hepatology. 2012;55(6):1912-21. doi: 10.1002/hep.25561.
10. Ivanova A.A., Maksimov V.N. Molecular genetic aspects of Gilbert’s syndrome, Crigler-Najjar syndromes types I and II. Experimental and Clinical Gastroenterology. 2022;(8):56-62. (In Russ.) doi: 10.31146/1682-8658-ecg-204-8-56-62.@@ Иванова А.А., Максимов В.Н. Молекулярно-генетические аспекты синдрома Жильбера, синдромов Криглера-Найяра I и II типов. Экспериментальная и клиническая гастроэнтерология. 2022;(8):56-62. doi: 10.31146/1682-8658-ecg-204-8-56-62.
11. Strassburg C.P. Pharmacogenetics of Gilbert’s syndrome. Pharmacogenomics. 2008;9(6):703-15. doi: 10.2217/14622416.9.6.703.
12. Botvinyev О., Dubrovina G., Kolotilina A. Gilbert’s syndrome and chromosome 2-mapped diseases. Vrach. 2015; 2: 40-42. (in Russ.)@@ Синдром Жильбера и болезни, картированные на 2-й хромосоме О. Ботвиньев О., Дубровина Г., Колотилина А. Врач. 2015; 2:40-42.
13. Wei Y., Liu C., Lai F. et al. Associations between serum total bilirubin, obesity and type 2 diabetes. Diabetol Metab Syndr. 2021; 7;13(1):143. doi: 10.1186/s13098-021-00762-0.
14. Drapkina O.M., Kravchenko A. Ya., Budnevsky A.V., Kontsevaya A.V., Ryaskina M.S., Chernik T.A. Bilirubin and cardiovascular risk.Russian Journal of Cardiology. 2021;26(9):4511. (In Russ.) doi: 10.15829/1560-4071-2021-4511.@@ Драпкина О.М., Кравченко А.Я., Будневский А.В., Концевая А.В., Ряскина М.С., Черник Т.А. Билирубин и сердечно-сосудистый риск. Российский кардиологический журнал. 2021;26(9):4511. doi: 10.15829/1560-4071-2021-4511.
15. Vitec L., Tiribelli С. Gilbert’s syndrome revisited. Hepatology. 2023; 71(8): 1-7. doi: 10.1016/j.jhep.2023.06.004.
Review
For citations:
Batdalova A.I., Ildarov K.F., Batchaeva T.M., Ovakimian D.V., Chernenkov Yu.V., Gumeniuk O.I. Comorbid conditions in Gilbert’s syndrome in children. Experimental and Clinical Gastroenterology. 2025;(1):96-98. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-233-1-96-98
Views:
77
Email this article 